Bladder Cancer
- Cancer PHGKB -
What's New
Last Posted: Aug 29, 2019
- SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018).
Gonz?lez Del Alba A et al. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2019 Jan 21(1) 64-74 - Biology of nonmuscle-invasive bladder cancer: pathology, genomic implications, and immunology.
Dyrskjøt Lars et al. Current opinion in urology 2018 28(6) 598-603 - Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer?
Grossman H Barton et al. European urology oncology 2019 Jul - Emerging genomic biomarkers for improving kidney, prostate, and bladder cancer health disparities outcomes.
Mitchell Khadijah A et al. Urologic oncology 2019 Jun - Identification of a nine-gene panel as a prognostic indicator for recurrence with muscle-invasive bladder cancer.
Han Yuying et al. Journal of surgical oncology 2019 Jun 119(8) 1145-1154 - Bladder cancer: Multi-omic profiling refines the molecular view.
Hurst Carolyn D et al. Nature reviews. Clinical oncology 2018 15(4) 203-204 - Identification of Hub Genes Associated With Progression and Prognosis in Patients With Bladder Cancer.
Yan Xin et al. Frontiers in genetics 2019 10408 - Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma.
Eich Marie-Lisa et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2019 Apr - Hope and challenge: Precision medicine in bladder cancer.
Su Hongwei et al. Cancer medicine 2019 Mar - Interest of next-generation sequencing in BCG-treated high-risk bladder cancer.
Jungels C et al. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 2018 May 28(6) 344-350 - Clinical and Genomic Considerations for Variant Histology in Bladder Cancer.
Matulay Justin T et al. Current oncology reports 2019 Feb 21(3) 23 - Ability of a urine gene expression classifier to reduce the number of follow-up cystoscopies in bladder cancer patients.
Montalbo Ruth et al. Translational research : the journal of laboratory and clinical medicine 2019 Feb - Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy.
van Kessel Kim E M et al. The Journal of urology 2017 197(3 Pt 1) 590-595 - Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer.
Meric-Bernstam Funda et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Nov - Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria.
Xu Yanjie et al. Urologic oncology 2018 Nov
No hay comentarios:
Publicar un comentario